2 recruiting. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow FOXR2-activated: new trials by email Literature Review of FOXR2-activated trials Research Report on FOXR2-activated
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors Personalized Treatment Recommendation - Rare CNS Tumor, FOXR2-activated | Not applicable | Recruiting | Adriana Fonseca | 20 | 2026-10-01 | 2026-10-13 |
| GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults GPC2-CAR T cells, Fludarabine, Cyclophosphamide - Medulloblastoma, Central Nervous System Embryonal Tumor | Phase 1 | Recruiting | Stanford University | 18 | 2025-08-28 | 2026-10-09 |
Brain Neoplasms (2) · Medulloblastoma (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors, Primitive (1) · Pinealoma (1) · Rhabdoid Tumor (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neuroectodermal Tumors (2) · Glioma (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Neuroepithelial (1)
Cyclophosphamide (1) · fludarabine (1)
Adriana Fonseca (1) · Stanford University (1)
United States (2)
Adriana Fonseca, MD (1) · Katherine Ryan, DO (1)